Product Detail
Labetalol-d3 Hydrochloride (Mixture of Diastereomers)
Impurity
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Impurity
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Labetalol-d3 Hydrochloride (Mixture of Diastereomers) Product Information
Labetalol-d3 Hydrochloride (Mixture of Diastereomers) is listed under Impurity. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-97367.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Labetalol-d3 Hydrochloride (Mixture of Diastereomers)
CAS No.
-
CAT No.
CS-T-97367
Molecular Formula
C19H22D3ClN2O3
Molecular Weight
367.88
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Labetalol-d3 Hydrochloride (Mixture of Diastereomers)
Hazard Compound
Refer MSDS for complete information.
Description
Overview
Labetalol-d3 Hydrochloride is labelled Labetalol Hydrochloride (L096495) which is specific competitive antagonist at both a-and ß-adrenergic receptor sites. Labetalol is used as an antihypertensive.
Synonyms
2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide-d3 Hydrochloride; 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide-d3 Monohydrochloride; AH 5158-d3 Hydrochloride; AH 5158A; Amipress-d3; Ipolab-d3; Labelol-d3; Labr
Application Notes
Labetalol-d3 Hydrochloride is labelled Labetalol Hydrochloride (L096495) which is specific competitive antagonist at both a-and ß-adrenergic receptor sites. Labetalol is used as an antihypertensive.
References
"Sybertz, E.J. et al.: J. Pharmacol. Exp. Ther., 218, 435 (1981); Clifton, J.E. et al.: J. Med. Chem., 25, 670 (1982); Goa, K.L. et al.: Drugs, 37, 583 (1989);"